PRactical utilization of Octapharma FVIII Concentrates in Previously Untreated and Minimally Treated Haemophilia A Patients Entering Routine Clinical Treatment (with Nuwiq, Octanate or Wilate). A Real-World Efficacy and Safety Observational Study

Principal Investigator

Dr Neha Bhatnagar

Contact us

Email: Paediatric.HaemophiliaClinic@ouh.nhs.uk

Phone: 01865226562

IRAS number

230615